Showing results (21-30 of 36) with videos related to

Sort By:
Pageof 4
Neuroscience Letters|June 1, 2005
Altered expression of myocilin in the brain of a mouse model for phenylketonuria (PKU)Sankar Surendran, Dena Matalon, Stephen K Tyring, et al.
Experimental Animals|April 27, 2007
Absence-like and tonic seizures in aspartoacylase/attractin double-mutant miceHiroshi Gohma, Takashi Kuramoto, Reuben Matalon, et al.
Pediatrics|December 5, 2003
Future role of large neutral amino acids in transport of phenylalanine into the brainReuben Matalon, Sankar Surendran, Kimberlee Michals Matalon, et al.
Molecular Genetics and Metabolism|October 22, 2003
Canavan disease: a monogenic trait with complex genomic interactionSankar Surendran, Kimberlee Michals-Matalon, Michael J Quast, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|August 6, 2004
Trends in enzyme therapy for phenylketonuriaWoomi Kim, Heidi Erlandsen, Sankar Surendran, et al.
Biochemical and Biophysical Research Communications|October 10, 2006
Hyaluronidase increases the biodistribution of acid alpha-1,4 glucosidase in the muscle of Pompe disease mice: an approach to enhance the efficacy of enzyme replacement therapyReuben Matalon, Sankar Surendran, Gerald A Campbell, et al.
American Journal of Medical Genetics|November 29, 2002
DOOR syndrome: deficiency of E1 component of the 2-oxoglutarate dehydrogenase complexSankar Surendran, Kimberlee Michals-Matalon, Stephan Krywawych, et al.
Genetic Testing|December 20, 2002
Founder mutation R245H of Sanfilippo syndrome type A in the Cayman IslandsPeter L Rady, Sankar Surendran, Ahn T Vu, et al.
Genetic Testing|July 14, 2007
Mutations in the regulatory domain of phenylalanine hydroxylase and response to tetrahydrobiopterinLin Wang, Sankar Surendran, Kimberlee Michals-Matalon, et al.
Pageof 4